A fairer deal for pneumococcal vaccination

South African Medical Journal

Volumn 99, Issue 12, 2009, Pages 836-837

  Ford, Nathan ^a   Berman, Daniel ^a   Frigati, Lisa ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BRAZIL; DEVELOPING COUNTRY; DRUG COST; GOVERNMENT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LETTER; PNEUMOCOCCAL INFECTION; SOUTH AFRICA; VACCINATION;

CHILD; DISEASE OUTBREAKS; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; SOUTH AFRICA; VACCINATION;

EID: 71949104046     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa's mothers, babies, and children: can the health system deliver? Lancet 2009; 374: 835-846.
2. Zar HJ, Madhi SA. Pneumococcal conjugate vaccine - a health priority. S Afr Med J 2008; 98(6): 463.
3. Jack A. GSK signs lifetime deal with Brazil for pneumococcal vaccine. Financial Times 28 September 2009.
4. United Nations Development Programme. Human Development Report. New York: United Nations, 2009.
5. Von Gottberg A, de Gouvbeia L, Quan V, et al. Vaccine-preventable invasive pneumococcal disease, South Africa. S Afr J Epidemiol Infect 2007; 22: 95 (abstract 101).
6. Maggon K. Global Vaccine Market Review 2008. Google Knol. http://knol.google.com/k/krishan-maggon/global-vaccine-market-review-2008-world/ 3fy5eowy8suq3/8# (accessed 5 November 2009).
7. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349: 1341-1348. (Pubitemid 37186212)